— Know what they know.
Not Investment Advice
Also trades as: ABL.DE (XETRA) · $vol 0M · ABT.SW (SIX) · $vol 0M

ABT NYSE

Abbott Laboratories
1W: +3.4% 1M: -4.3% 3M: -21.8% YTD: -29.0% 1Y: -34.5% 3Y: -15.8% 5Y: -19.4%
$87.41
-0.36 (-0.41%)
 
Weekly Expected Move ±3.6%
$78 $81 $84 $88 $91
NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 52 · $152.3B mcap · 1.73B float · 0.709% daily turnover · Short 29% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
55.3 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 10.9%  ·  5Y Avg: 15.2%
Cost Advantage
75
Intangibles
51
Switching Cost
23
Network Effect
55
Scale ★
90
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ABT has a Narrow competitive edge (55.3/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 10.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$92
Low
$117
Avg Target
$143
High
Based on 5 analysts since Apr 16, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 31Hold: 10Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$126.86
Analysts7
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-21 Daiwa Initiated $92 -0.8% $92.75
2026-04-20 Barclays Matt Miksic $142 $143 +1 +47.7% $96.83
2026-04-17 UBS $158 $115 -43 +20.5% $95.46
2026-04-17 Piper Sandler $135 $115 -20 +20.5% $95.46
2026-04-17 Stifel Nicolaus $126 $120 -6 +25.7% $95.46
2026-03-13 UBS Danielle Antalffy $132 $158 +26 +45.7% $108.42
2026-03-13 New Street $117 $145 +28 +34.1% $108.14
2026-02-02 Barclays $169 $142 -27 +29.9% $109.30
2026-01-29 Loop Capital Markets Ilya Zubkov Initiated $120 +13.1% $106.09
2026-01-23 Evercore ISI $144 $138 -6 +27.1% $108.61
2026-01-23 UBS $128 $132 +4 +21.5% $108.60
2026-01-23 Mizuho Securities Anthony Petrone Initiated $125 +15.1% $108.60
2026-01-23 Piper Sandler $133 $135 +2 +24.3% $108.60
2026-01-23 Bernstein $154 $125 -29 +15.1% $108.60
2026-01-23 Wells Fargo Larry Biegelsen $146 $122 -24 +12.3% $108.60
2026-01-09 Bernstein Lee Hambright $135 $154 +19 +22.0% $126.18
2026-01-09 Goldman Sachs $157 $152 -5 +20.5% $126.18
2026-01-05 Evercore ISI $128 $144 +16 +16.2% $123.97
2026-01-05 Barclays $162 $169 +7 +36.1% $124.19
2025-12-22 BTIG Marie Thibault $139 $145 +6 +14.9% $126.24
2025-11-21 Tigress Financial Initiated $145 +13.2% $128.12
2025-10-17 Barclays $140 $162 +22 +26.9% $127.63
2025-10-16 Wells Fargo $150 $146 -4 +12.8% $129.45
2025-10-01 Goldman Sachs $121 $157 +36 +17.2% $133.94
2025-07-15 RBC Capital Shagun Singh $140 $147 +7 +11.8% $131.49
2025-04-15 RBC Capital Shagun Singh $130 $140 +10 +10.9% $126.22
2025-01-08 Bernstein Lee Hambright $138 $135 -3 +18.2% $114.25
2024-10-17 Piper Sandler Adam Maeder $131 $133 +2 +12.9% $117.82
2024-10-17 Bernstein Lee Hambright $133 $138 +5 +17.1% $117.82
2024-10-16 Jefferies Matthew Taylor $120 $125 +5 +6.1% $117.82
2024-10-16 Evercore ISI Vijay Kumar $120 $128 +8 +8.6% $117.82
2024-10-16 BTIG Marie Thibault $135 $139 +4 +18.0% $117.82
2024-10-08 Oppenheimer Suraj Kalia Initiated $130 +13.7% $114.30
2024-10-08 RBC Capital Shagun Singh $345 $130 -215 +14.7% $113.36
2024-09-19 RBC Capital Jonathan Atkin $125 $345 +220 +533.1% $54.49
2024-09-19 Piper Sandler Adam Maeder Initiated $131 +14.0% $114.88
2024-08-27 Jefferies Matthew Taylor $145 $120 -25 +6.9% $112.22
2024-08-22 Citigroup Joanne Wuensch $119 $127 +8 +14.0% $111.39
2024-07-17 Citigroup Joanna Wiensch $125 $119 -6 +13.7% $104.68
2024-07-02 Evercore ISI Vijay Kumar Initiated $120 +16.3% $103.20
2024-06-03 BTIG Marie Thibault $126 $135 +9 +31.1% $102.99
2024-05-30 Goldman Sachs David Roman $120 $121 +1 +20.1% $100.73
2024-04-21 Barclays Matt Miksic Initiated $140 +30.8% $107.07
2024-04-18 Bernstein Lee Hambright Initiated $133 +26.3% $105.27
2024-04-18 RBC Capital Shagun Singh $132 $125 -7 +18.0% $105.90
2023-01-06 Morgan Stanley $151 $133 -18 +19.4% $111.37
2022-12-12 Citigroup $123 $125 +2 +16.3% $107.51
2022-08-03 RBC Capital Shagun Singh $143 $132 -11 +20.2% $109.78
2022-07-27 UBS Initiated $128 +17.3% $109.09
2022-07-21 Citigroup $154 $123 -31 +13.6% $108.23

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
4
ROE
4
ROA
5
D/E
1
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ABT receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-14 B B+
2026-04-29 C B
2026-04-17 B+ C
2026-03-30 B B+
2026-03-10 B+ B
2026-02-23 C B+
2026-01-26 C- C
2026-01-23 A- C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

57 Grade A
Profitability
52
Balance Sheet
78
Earnings Quality
75
Growth
27
Value
49
Momentum
59
Safety
100
Cash Flow
68
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ABT scores highest in Safety (100/100) and lowest in Growth (27/100). An overall grade of A places ABT among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.94
Safe Zone
Piotroski F-Score
7/9
Beneish M-Score
-2.55
Unlikely Manipulator
Ohlson O-Score
-9.81
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA
Score: 89.5/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.51x
Accruals: -3.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ABT scores 4.94, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ABT scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ABT's score of -2.55 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ABT's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ABT receives an estimated rating of AA (score: 89.5/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ABT's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
24.33x
PEG
-0.45x
P/S
3.37x
P/B
2.93x
P/FCF
24.16x
P/OCF
18.83x
EV/EBITDA
17.07x
EV/Revenue
4.09x
EV/EBIT
20.92x
EV/FCF
24.99x
Earnings Yield
3.52%
FCF Yield
4.14%
Shareholder Yield
2.79%
Graham Number
$49.11
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 24.3x earnings, ABT commands a growth premium. Graham's intrinsic value formula yields $49.11 per share, 78% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.771
NI / EBT
×
Interest Burden
0.923
EBT / EBIT
×
EBIT Margin
0.195
EBIT / Rev
×
Asset Turnover
0.537
Rev / Assets
×
Equity Multiplier
1.685
Assets / Equity
=
ROE
12.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ABT's ROE of 12.6% is driven by Asset Turnover (0.537), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
2.73%
Fair P/E
13.97x
Intrinsic Value
$50.17
Price/Value
2.03x
Margin of Safety
-103.37%
Premium
103.37%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ABT's realized 2.7% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. ABT trades at a 103% premium to its adjusted intrinsic value of $50.17, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 14.0x compares to the current market P/E of 24.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$87.41
Median 1Y
$87.51
5th Pctile
$58.54
95th Pctile
$131.07
Ann. Volatility
25.1%
Analyst Target
$126.86
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Philip P. Boudreau
, Executive Vice President, Finance and Chief Financial Officer
$974,231 $3,045,935 $9,090,636
Lisa D. Earnhardt
, Executive Vice President and Group President, Medical Devices
$924,231 $2,543,989 $8,069,724
Hubert L. Allen
, Former Executive Vice President, General Counsel and Secretary
$524,019 $2,095,392 $6,995,583
Christopher J. Scoggins
, Executive Vice President, Diabetes Care
$859,502 $1,662,503 $6,601,667
Daniel G. Salvadori
, Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products
$924,231 $2,238,786 $6,534,285

CEO Pay Ratio

212:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $22,777,075
Avg Employee Cost (SGA/emp): $107,635
Employees: 115,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
115,000
+0.9% YoY
Revenue / Employee
$385,461
Rev: $44,328,000,000
Profit / Employee
$56,730
NI: $6,524,000,000
SGA / Employee
$107,635
Avg labor cost proxy
R&D / Employee
$25,696
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 20.0% 22.7% 20.6% 22.5% 24.9% 23.0% 19.1% 16.0% 14.2% 14.2% 15.2% 15.0% 14.8% 15.3% 31.1% 31.3% 32.4% 32.4% 13.1% 12.6% 12.58%
ROA 9.1% 10.3% 9.6% 10.5% 11.6% 10.7% 9.3% 7.8% 6.9% 6.9% 7.8% 7.6% 7.5% 7.8% 17.3% 17.5% 18.1% 18.1% 7.8% 7.5% 7.47%
ROIC 15.6% 17.6% 17.7% 19.0% 19.5% 17.7% 15.7% 12.8% 11.2% 11.3% 11.7% 11.7% 12.0% 12.2% 23.9% 24.0% 24.3% 24.3% 10.6% 10.9% 10.86%
ROCE 12.6% 14.4% 13.9% 15.1% 16.7% 15.4% 14.6% 12.7% 11.6% 11.6% 12.4% 12.1% 12.1% 12.6% 11.3% 11.9% 12.6% 12.9% 12.7% 12.6% 12.55%
Gross Margin 52.6% 55.5% 54.1% 53.5% 51.3% 50.0% 49.3% 49.3% 49.6% 49.6% 51.3% 50.4% 51.1% 51.0% 51.0% 52.6% 56.4% 55.7% 57.0% 56.3% 56.28%
Operating Margin 19.5% 24.0% 21.3% 24.3% 20.7% 16.4% 14.3% 14.4% 15.1% 16.5% 18.2% 13.9% 16.2% 17.1% 18.1% 16.3% 18.4% 18.1% 19.6% 16.5% 16.50%
Net Margin 11.6% 19.2% 17.3% 20.6% 17.9% 13.8% 10.2% 13.5% 13.8% 14.2% 15.6% 12.3% 12.5% 15.5% 84.1% 12.8% 16.0% 14.5% 15.5% 9.6% 9.65%
EBITDA Margin 23.1% 31.7% 28.8% 31.2% 29.0% 25.3% 22.7% 26.0% 25.9% 26.1% 27.8% 23.7% 24.9% 27.3% 27.2% 25.8% 27.4% 27.2% 24.6% 16.5% 16.50%
FCF Margin 21.5% 22.0% 20.1% 18.3% 18.6% 19.0% 17.9% 16.4% 13.6% 11.2% 12.6% 12.2% 13.9% 15.7% 15.1% 15.7% 15.7% 15.8% 16.7% 16.3% 16.35%
OCF Margin 26.4% 26.6% 24.5% 22.4% 22.5% 22.9% 21.9% 20.9% 18.5% 16.4% 18.1% 17.7% 19.4% 21.2% 20.4% 21.1% 21.0% 20.8% 21.6% 21.0% 20.97%
ROE 3Y Avg snapshot only 18.32%
ROE 5Y Avg snapshot only 18.47%
ROA 3Y Avg snapshot only 10.50%
ROIC 3Y Avg snapshot only 12.97%
ROIC Economic snapshot only 9.54%
Cash ROA snapshot only 10.91%
Cash ROIC snapshot only 16.24%
CROIC snapshot only 12.66%
NOPAT Margin snapshot only 14.02%
Pretax Margin snapshot only 18.03%
R&D / Revenue snapshot only 6.66%
SGA / Revenue snapshot only 27.89%
SBC / Revenue snapshot only 1.53%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 30.01 26.96 32.90 25.32 20.95 20.31 26.20 28.96 35.21 31.39 32.35 34.16 31.81 33.75 14.46 16.94 16.88 16.69 33.55 28.40 24.331
P/S Ratio 4.76 4.62 5.40 4.39 3.94 3.56 4.16 4.05 4.52 4.05 4.62 4.77 4.34 4.72 4.62 5.40 5.48 5.32 4.94 3.95 3.373
P/B Ratio 5.84 5.96 6.50 5.46 5.01 4.48 4.95 4.58 4.95 4.42 4.80 4.98 4.58 5.04 4.07 4.80 4.95 4.89 4.20 3.42 2.933
P/FCF 22.14 20.97 26.90 23.99 21.17 18.76 23.28 24.63 33.11 36.07 36.59 39.06 31.27 30.01 30.52 34.35 34.84 33.72 29.60 24.16 24.159
P/OCF 18.00 17.34 22.09 19.64 17.50 15.52 18.96 19.41 24.38 24.74 25.49 26.92 22.38 22.30 22.65 25.55 26.12 25.58 22.88 18.83 18.834
EV/EBITDA 18.35 17.01 19.87 15.95 13.71 13.12 15.93 16.42 18.88 16.89 18.27 19.26 17.78 19.02 18.56 21.17 20.96 20.39 19.35 17.07 17.065
EV/Revenue 5.07 4.92 5.61 4.60 4.13 3.76 4.34 4.24 4.71 4.25 4.83 4.98 4.55 4.93 4.79 5.57 5.64 5.49 5.08 4.09 4.085
EV/EBIT 26.71 23.89 28.03 21.77 18.19 17.72 21.97 23.58 27.82 24.91 26.31 27.94 25.83 27.23 26.41 29.59 28.73 27.76 25.33 20.92 20.918
EV/FCF 23.61 22.34 27.94 25.10 22.23 19.82 24.27 25.77 34.53 37.80 38.29 40.81 32.79 31.34 31.67 35.45 35.92 34.77 30.43 24.99 24.990
Earnings Yield 3.3% 3.7% 3.0% 3.9% 4.8% 4.9% 3.8% 3.5% 2.8% 3.2% 3.1% 2.9% 3.1% 3.0% 6.9% 5.9% 5.9% 6.0% 3.0% 3.5% 3.52%
FCF Yield 4.5% 4.8% 3.7% 4.2% 4.7% 5.3% 4.3% 4.1% 3.0% 2.8% 2.7% 2.6% 3.2% 3.3% 3.3% 2.9% 2.9% 3.0% 3.4% 4.1% 4.14%
Price/Tangible Book snapshot only 7.898
EV/OCF snapshot only 19.482
EV/Gross Profit snapshot only 7.246
Acquirers Multiple snapshot only 22.479
Shareholder Yield snapshot only 2.79%
Graham Number snapshot only $49.11
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.72 1.72 1.85 1.85 1.85 1.85 1.63 1.63 1.63 1.63 1.64 1.64 1.64 1.64 1.67 1.67 1.67 1.67 1.58 1.58 1.576
Quick Ratio 1.30 1.30 1.46 1.46 1.46 1.46 1.23 1.23 1.23 1.23 1.16 1.16 1.16 1.16 1.23 1.23 1.23 1.23 1.18 1.18 1.183
Debt/Equity 0.61 0.61 0.54 0.54 0.54 0.54 0.49 0.49 0.49 0.49 0.41 0.41 0.41 0.41 0.32 0.32 0.32 0.32 0.29 0.29 0.289
Net Debt/Equity 0.39 0.39 0.25 0.25 0.25 0.25 0.21 0.21 0.21 0.21 0.22 0.22 0.22 0.22 0.15 0.15 0.15 0.15 0.12 0.12 0.118
Debt/Assets 0.27 0.27 0.26 0.26 0.26 0.26 0.24 0.24 0.24 0.24 0.22 0.22 0.22 0.22 0.19 0.19 0.19 0.19 0.17 0.17 0.174
Debt/EBITDA 1.79 1.63 1.58 1.50 1.40 1.49 1.51 1.68 1.79 1.79 1.50 1.52 1.52 1.49 1.41 1.37 1.32 1.29 1.30 1.39 1.395
Net Debt/EBITDA 1.15 1.04 0.74 0.70 0.66 0.70 0.65 0.73 0.77 0.77 0.81 0.82 0.82 0.80 0.67 0.66 0.63 0.62 0.53 0.57 0.567
Interest Coverage 17.29 20.02 21.03 26.55 34.16 39.80 27.37 15.97 12.73 10.87 10.55 11.01 10.74 10.88 12.63 12.86 14.78 19.22 26.05 32.05 32.051
Equity Multiplier 2.21 2.21 2.10 2.10 2.10 2.10 2.03 2.03 2.03 2.03 1.90 1.90 1.90 1.90 1.71 1.71 1.71 1.71 1.66 1.66 1.663
Cash Ratio snapshot only 0.542
Debt Service Coverage snapshot only 39.287
Cash to Debt snapshot only 0.593
FCF to Debt snapshot only 0.490
Defensive Interval snapshot only 356.5 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.57 0.60 0.58 0.60 0.62 0.61 0.58 0.55 0.54 0.53 0.54 0.55 0.55 0.56 0.54 0.55 0.56 0.57 0.53 0.54 0.537
Inventory Turnover 4.13 4.21 3.91 4.03 4.16 4.22 3.77 3.66 3.58 3.57 3.15 3.15 3.16 3.17 3.23 3.22 3.19 3.16 3.11 3.10 3.105
Receivables Turnover 6.80 7.15 6.68 6.90 7.06 6.98 6.87 6.53 6.33 6.29 6.28 6.31 6.37 6.45 6.22 6.28 6.39 6.50 5.97 6.08 6.077
Payables Turnover 5.35 5.45 4.75 4.91 5.06 5.14 4.73 4.60 4.50 4.48 4.51 4.51 4.52 4.54 4.85 4.85 4.79 4.75 4.68 4.67 4.668
DSO 54 51 55 53 52 52 53 56 58 58 58 58 57 57 59 58 57 56 61 60 60.1 days
DIO 88 87 93 91 88 86 97 100 102 102 116 116 116 115 113 113 114 115 117 118 117.6 days
DPO 68 67 77 74 72 71 77 79 81 81 81 81 81 80 75 75 76 77 78 78 78.2 days
Cash Conversion Cycle 74 71 71 69 67 68 73 76 78 79 93 93 92 91 97 96 95 95 100 99 99.4 days
Fixed Asset Turnover snapshot only 3.487
Operating Cycle snapshot only 177.6 days
Cash Velocity snapshot only 5.049
Capital Intensity snapshot only 1.921
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 28.0% 31.3% 24.5% 19.2% 13.2% 6.4% 1.3% -6.8% -11.7% -11.3% -8.1% -2.8% 1.2% 3.1% 4.6% 5.0% 5.9% 6.4% 5.7% 6.6% 6.59%
Net Income 1.1% 1.1% 57.3% 35.0% 34.2% 8.9% -2.0% -24.9% -39.7% -34.6% -17.5% -3.0% 7.7% 11.7% 1.3% 1.4% 1.5% 1.4% -51.3% -53.5% -53.52%
EPS 1.0% 1.1% 57.9% 36.3% 36.3% 10.4% -0.4% -23.9% -39.2% -34.0% -17.2% -2.9% 7.6% 11.7% 1.3% 1.4% 1.5% 1.4% -51.3% -53.5% -53.51%
FCF 89.4% 1.0% 51.1% 7.1% -2.0% -8.3% -9.8% -16.3% -35.2% -47.4% -35.2% -27.8% 3.0% 44.4% 25.5% 35.2% 19.8% 6.6% 16.4% 10.8% 10.83%
EBITDA 48.9% 57.4% 35.1% 24.8% 23.4% 5.5% -2.2% -16.5% -26.9% -22.0% -10.8% -2.6% 3.8% 6.3% 2.2% 6.8% 11.4% 10.4% 7.3% -3.1% -3.05%
Op. Income 98.6% 1.1% 73.9% 49.8% 28.6% 2.2% -9.1% -30.9% -41.1% -35.6% -22.8% -6.4% 9.2% 12.0% 6.6% 11.6% 14.1% 15.3% 17.0% 14.2% 14.20%
OCF Growth snapshot only 5.74%
Asset Growth snapshot only 6.51%
Equity Growth snapshot only 9.37%
Debt Growth snapshot only -1.36%
Shares Change snapshot only -0.01%
Dividend Growth snapshot only 7.25%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 10.8% 11.6% 12.1% 13.2% 13.8% 12.8% 11.0% 8.9% 8.6% 7.4% 5.0% 2.6% 0.4% -0.9% -0.9% -1.7% -1.8% -0.9% 0.5% 2.8% 2.83%
Revenue 5Y 14.4% 15.4% 15.6% 14.8% 14.0% 12.4% 9.8% 7.8% 6.3% 5.6% 5.6% 5.6% 5.7% 5.6% 5.6% 5.7% 6.5% 6.4% 5.1% 3.9% 3.87%
EPS 3Y 89.4% 1.0% 43.8% 43.4% 43.9% 34.3% 24.1% 18.1% 19.2% 16.0% 9.2% 0.2% -3.7% -6.6% 24.6% 21.1% 18.1% 21.3% -1.9% 2.7% 2.73%
EPS 5Y 18.2% 34.3% 33.3% 38.1% 48.6% 30.1% 70.6% 65.2% 41.3% 42.6% 19.7% 16.9% 14.3% 12.3% 30.0% 30.9% 35.6% 33.4% 8.2% 2.4% 2.38%
Net Income 3Y 90.2% 1.0% 44.0% 43.4% 43.5% 33.8% 23.4% 17.5% 18.4% 15.1% 8.4% -0.6% -4.5% -7.3% 23.8% 20.5% 17.8% 21.0% -2.0% 2.6% 2.64%
Net Income 5Y 22.9% 39.5% 38.3% 38.7% 48.8% 30.3% 70.8% 64.9% 41.0% 42.3% 19.3% 16.5% 13.9% 11.9% 29.4% 30.4% 35.1% 32.8% 7.7% 1.9% 1.86%
EBITDA 3Y 20.0% 23.3% 20.9% 21.9% 22.9% 18.5% 14.6% 9.9% 10.3% 9.0% 5.6% 0.5% -2.1% -4.4% -3.8% -4.6% -5.4% -2.9% -0.7% 0.3% 0.29%
EBITDA 5Y 23.0% 32.1% 33.0% 24.8% 26.5% 18.1% 14.3% 13.0% 9.3% 9.0% 9.0% 8.1% 7.1% 6.6% 6.5% 6.6% 9.2% 8.7% 5.3% 1.0% 1.00%
Gross Profit 3Y 11.8% 13.5% 13.6% 14.6% 14.7% 12.9% 10.2% 7.6% 7.7% 7.1% 4.9% 2.0% -0.6% -2.5% -2.8% -3.2% -2.3% 0.2% 3.3% 7.0% 7.02%
Gross Profit 5Y 12.4% 14.3% 14.9% 15.6% 16.0% 14.0% 11.3% 8.0% 5.8% 4.9% 4.8% 4.9% 5.0% 5.1% 5.1% 5.5% 7.4% 8.0% 7.2% 5.9% 5.94%
Op. Income 3Y 34.9% 39.1% 33.8% 36.3% 35.1% 29.4% 22.4% 14.5% 14.6% 12.1% 6.8% -1.0% -6.2% -9.7% -9.2% -10.3% -9.8% -6.0% -1.3% 6.0% 6.05%
Op. Income 5Y 22.8% 24.4% 23.3% 30.4% 36.0% 33.6% 33.6% 20.6% 13.2% 12.1% 10.9% 10.4% 9.6% 9.3% 8.6% 9.4% 13.4% 12.7% 8.8% 4.3% 4.30%
FCF 3Y 21.5% 23.8% 20.8% 22.4% 27.4% 30.8% 20.2% 15.1% 6.3% -0.7% -4.0% -13.5% -13.2% -11.4% -9.8% -6.5% -7.2% -6.8% -1.8% 2.6% 2.64%
FCF 5Y 38.6% 38.8% 32.9% 24.5% 21.8% 16.4% 12.0% 6.6% 2.6% -1.7% 0.6% 2.0% 6.7% 11.2% 7.1% 8.3% 8.2% 8.6% 5.3% -0.6% -0.61%
OCF 3Y 21.0% 22.2% 18.7% 19.0% 21.4% 23.5% 16.0% 12.1% 5.2% 0.2% -2.8% -10.1% -9.4% -8.2% -6.7% -3.5% -4.1% -4.0% -0.1% 3.0% 3.01%
OCF 5Y 30.2% 31.5% 26.9% 20.8% 18.9% 15.1% 11.5% 7.2% 4.4% 1.2% 2.9% 3.9% 6.7% 9.7% 6.9% 7.8% 7.1% 6.9% 3.9% -0.7% -0.74%
Assets 3Y -1.6% -1.6% 3.8% 3.8% 3.8% 3.8% 3.1% 3.1% 3.1% 3.1% 0.3% 0.3% 0.3% 0.3% 2.7% 2.7% 2.7% 2.7% 5.2% 5.2% 5.22%
Assets 5Y 10.5% 10.5% 6.5% 6.5% 6.5% 6.5% -0.5% -0.5% -0.5% -0.5% 1.7% 1.7% 1.7% 1.7% 3.7% 3.7% 3.7% 3.7% 3.6% 3.6% 3.63%
Equity 3Y 2.0% 2.0% 5.5% 5.5% 5.5% 5.5% 5.7% 5.7% 5.7% 5.7% 5.6% 5.6% 5.6% 5.6% 10.0% 10.0% 10.0% 10.0% 12.4% 12.4% 12.42%
Book Value 3Y 1.5% 1.7% 5.3% 5.5% 5.8% 5.9% 6.2% 6.3% 6.4% 6.5% 6.4% 6.4% 6.4% 6.4% 10.8% 10.6% 10.3% 10.3% 12.6% 12.5% 12.53%
Dividend 3Y 5.6% 6.6% 7.6% 6.0% 4.5% 2.9% 1.6% 1.9% 2.4% 2.8% 3.2% 3.3% 3.3% 3.4% 3.3% 3.1% 2.7% 2.7% 2.5% 2.5% 2.45%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.91 0.89 0.95 0.96 0.93 0.92 0.92 0.85 0.71 0.65 0.68 0.61 0.48 0.43 0.47 0.44 0.44 0.51 0.64 0.87 0.868
Earnings Stability 0.59 0.69 0.88 0.89 0.89 0.83 0.96 0.82 0.65 0.62 0.69 0.49 0.30 0.26 0.65 0.54 0.47 0.45 0.23 0.12 0.120
Margin Stability 0.95 0.95 0.96 0.98 0.97 0.96 0.96 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.96 0.96 0.95 0.950
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.86 0.86 0.96 0.99 0.90 0.84 0.86 0.93 0.99 0.97 0.95 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.31 0.27 0.55 0.70 0.71 0.91 0.98 0.72 0.51 0.58 0.81 0.97 0.93 0.89 0.20 0.18 0.14 0.17 0.31 0.27 0.269
ROE Trend 0.10 0.11 0.07 0.07 0.09 0.06 0.02 -0.04 -0.08 -0.08 -0.04 -0.04 -0.05 -0.03 0.11 0.13 0.15 0.15 -0.09 -0.09 -0.094
Gross Margin Trend 0.01 0.03 0.03 0.02 0.02 0.01 -0.01 -0.02 -0.03 -0.04 -0.03 -0.02 -0.01 0.00 0.00 0.01 0.03 0.04 0.05 0.06 0.056
FCF Margin Trend 0.08 0.09 0.05 0.01 0.01 0.01 -0.00 -0.03 -0.06 -0.09 -0.06 -0.05 -0.02 0.01 -0.00 0.01 0.02 0.02 0.03 0.02 0.024
Sustainable Growth Rate 10.9% 13.1% 11.3% 13.1% 15.4% 13.4% 10.0% 6.7% 4.8% 4.6% 5.8% 5.3% 4.9% 5.3% 22.2% 22.2% 23.2% 23.0% 4.8% 4.2% 4.18%
Internal Growth Rate 5.2% 6.4% 5.5% 6.5% 7.7% 6.6% 5.1% 3.4% 2.4% 2.3% 3.0% 2.8% 2.6% 2.8% 14.1% 14.2% 14.9% 14.7% 2.9% 2.5% 2.55%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.67 1.55 1.49 1.29 1.20 1.31 1.38 1.49 1.44 1.27 1.27 1.27 1.42 1.51 0.64 0.66 0.65 0.65 1.47 1.51 1.508
FCF/OCF 0.81 0.83 0.82 0.82 0.83 0.83 0.81 0.79 0.74 0.69 0.70 0.69 0.72 0.74 0.74 0.74 0.75 0.76 0.77 0.78 0.780
FCF/Net Income snapshot only 1.176
OCF/EBITDA snapshot only 0.876
CapEx/Revenue 4.9% 4.6% 4.4% 4.1% 3.9% 4.0% 4.1% 4.4% 4.9% 5.1% 5.5% 5.5% 5.5% 5.4% 5.3% 5.4% 5.2% 5.0% 4.9% 4.6% 4.62%
CapEx/Depreciation snapshot only 1.048
Accruals Ratio -0.06 -0.06 -0.05 -0.03 -0.02 -0.03 -0.04 -0.04 -0.03 -0.02 -0.02 -0.02 -0.03 -0.04 0.06 0.06 0.06 0.06 -0.04 -0.04 -0.038
Sloan Accruals snapshot only -0.024
Cash Flow Adequacy snapshot only 1.508
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 1.5% 1.6% 1.4% 1.7% 1.8% 2.0% 1.8% 2.0% 1.9% 2.2% 1.9% 1.9% 2.1% 1.9% 2.0% 1.7% 1.7% 1.7% 1.9% 2.3% 2.79%
Dividend/Share $1.61 $1.70 $1.80 $1.82 $1.85 $1.86 $1.89 $1.92 $1.96 $2.00 $2.03 $2.07 $2.11 $2.15 $2.20 $2.23 $2.27 $2.31 $2.36 $2.40 $2.44
Payout Ratio 45.2% 42.0% 45.3% 41.9% 38.1% 41.6% 47.7% 58.0% 66.4% 67.6% 62.1% 64.4% 66.5% 65.3% 28.6% 28.9% 28.4% 28.9% 63.1% 66.7% 66.73%
FCF Payout Ratio 33.4% 32.7% 37.0% 39.7% 38.5% 38.4% 42.4% 49.3% 62.5% 77.7% 70.3% 73.6% 65.3% 58.1% 60.4% 58.7% 58.6% 58.5% 55.7% 56.8% 56.76%
Total Payout Ratio 59.5% 62.5% 77.8% 97.9% 83.3% 93.4% 1.0% 93.0% 1.1% 99.7% 83.6% 80.6% 75.3% 86.8% 38.3% 38.9% 38.1% 35.4% 76.8% 79.4% 79.37%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.21 0.24 0.26 0.20 0.15 0.10 0.05 0.06 0.07 0.08 0.09 0.09 0.10 0.10 0.10 0.09 0.09 0.09 0.09 0.10 0.096
Buyback Yield 0.5% 0.8% 1.0% 2.2% 2.2% 2.5% 2.1% 1.2% 1.3% 1.0% 0.7% 0.5% 0.3% 0.6% 0.7% 0.6% 0.6% 0.4% 0.4% 0.4% 0.44%
Net Buyback Yield 0.5% 0.8% 1.0% 2.2% 2.2% 2.5% 2.1% 1.2% 1.3% 1.0% 0.7% 0.5% 0.3% 0.6% 0.7% 0.6% 0.6% 0.4% 0.4% 0.3% 0.34%
Total Shareholder Return 2.0% 2.3% 2.4% 3.9% 4.0% 4.6% 3.9% 3.2% 3.2% 3.2% 2.6% 2.4% 2.4% 2.6% 2.6% 2.3% 2.3% 2.1% 2.3% 2.7% 2.69%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.89 0.88 0.86 0.85 0.85 0.85 0.83 0.83 0.82 0.83 0.86 0.86 0.85 0.85 1.91 1.84 1.77 1.72 0.77 0.77 0.771
Interest Burden (EBT/EBIT) 0.94 0.95 0.95 0.96 0.97 0.97 0.96 0.94 0.92 0.91 0.91 0.91 0.91 0.91 0.92 0.92 0.93 0.94 0.95 0.92 0.923
EBIT Margin 0.19 0.21 0.20 0.21 0.23 0.21 0.20 0.18 0.17 0.17 0.18 0.18 0.18 0.18 0.18 0.19 0.20 0.20 0.20 0.20 0.195
Asset Turnover 0.57 0.60 0.58 0.60 0.62 0.61 0.58 0.55 0.54 0.53 0.54 0.55 0.55 0.56 0.54 0.55 0.56 0.57 0.53 0.54 0.537
Equity Multiplier 2.20 2.20 2.15 2.15 2.15 2.15 2.06 2.06 2.06 2.06 1.96 1.96 1.96 1.96 1.79 1.79 1.79 1.79 1.68 1.68 1.685
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $3.56 $4.05 $3.97 $4.35 $4.85 $4.47 $3.95 $3.31 $2.95 $2.95 $3.27 $3.22 $3.17 $3.30 $7.68 $7.73 $7.98 $7.99 $3.73 $3.59 $3.59
Book Value/Share $18.28 $18.33 $20.09 $20.17 $20.28 $20.30 $20.92 $20.94 $20.96 $20.98 $22.08 $22.06 $22.05 $22.08 $27.30 $27.28 $27.22 $27.25 $29.84 $29.84 $30.17
Tangible Book/Share $-3.20 $-3.21 $-0.09 $-0.09 $-0.10 $-0.10 $1.96 $1.96 $1.96 $1.96 $3.49 $3.49 $3.49 $3.49 $10.26 $10.25 $10.23 $10.24 $12.92 $12.92 $12.92
Revenue/Share $22.44 $23.65 $24.17 $25.08 $25.81 $25.53 $24.89 $23.69 $22.98 $22.86 $22.95 $23.04 $23.26 $23.58 $24.03 $24.24 $24.62 $25.07 $25.37 $25.84 $25.84
FCF/Share $4.82 $5.21 $4.85 $4.59 $4.80 $4.84 $4.45 $3.90 $3.14 $2.57 $2.89 $2.81 $3.23 $3.71 $3.64 $3.81 $3.87 $3.95 $4.23 $4.22 $4.22
OCF/Share $5.93 $6.30 $5.91 $5.61 $5.80 $5.85 $5.46 $4.94 $4.26 $3.75 $4.15 $4.08 $4.51 $4.99 $4.90 $5.12 $5.16 $5.21 $5.48 $5.42 $5.42
Cash/Share $3.99 $4.00 $5.75 $5.77 $5.81 $5.81 $5.80 $5.81 $5.81 $5.82 $4.16 $4.16 $4.16 $4.16 $4.56 $4.56 $4.55 $4.56 $5.12 $5.12 $4.18
EBITDA/Share $6.20 $6.84 $6.82 $7.23 $7.78 $7.31 $6.78 $6.11 $5.74 $5.75 $6.07 $5.96 $5.95 $6.11 $6.21 $6.38 $6.63 $6.74 $6.66 $6.18 $6.18
Debt/Share $11.09 $11.12 $10.80 $10.85 $10.91 $10.91 $10.23 $10.24 $10.25 $10.26 $9.08 $9.07 $9.07 $9.08 $8.75 $8.74 $8.72 $8.73 $8.62 $8.62 $8.62
Net Debt/Share $7.11 $7.12 $5.05 $5.07 $5.10 $5.10 $4.43 $4.44 $4.44 $4.45 $4.92 $4.91 $4.91 $4.92 $4.19 $4.18 $4.17 $4.18 $3.51 $3.51 $3.51
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 4.942
Altman Z-Prime snapshot only 8.787
Piotroski F-Score 8 8 9 9 8 8 5 4 4 4 6 6 7 8 6 7 8 7 6 7 7
Beneish M-Score -2.58 -2.64 -2.72 -2.59 -2.56 -2.58 -2.65 -2.67 -2.67 -2.62 -2.53 -2.54 -2.60 -2.63 -2.09 -2.14 -2.14 -2.14 -2.57 -2.55 -2.549
Ohlson O-Score snapshot only -9.810
ROIC (Greenblatt) snapshot only 39.27%
Net-Net WC snapshot only $-4.55
EVA snapshot only $500333956.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA
Credit Score 85.84 86.57 88.68 88.35 89.21 89.33 90.25 87.68 87.19 85.48 87.17 86.47 86.99 86.42 86.90 86.54 87.23 87.84 90.29 89.46 89.465
Credit Grade snapshot only 3
Credit Trend snapshot only 2.922
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 81
Sector Credit Rank snapshot only 85

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms